General Information
Version
00
Revision date
2025-11-14
Product name
Sodium oxybate, 0.5 g/mL Oral solution
Product name
Sodium oxybate, 0.5 g/mL Oral solution
Identification on the label/Trade name
Sodium oxybate, 0.5 g/mL oral solution
Product Synonyms
sodium oxybate, sodium gamma-hydroxybutyrate; butanoic acid, 4- sodium oxybate, sodium gamma-hydroxybutyrate; butanoic acid, 4-hydroxybutyrate monosodium salt
CAS No.
502-85-2
Emergency telephone
1-855-221-1622
Icons in SDS
Company Information
company name
Ascent Pharmaceuticals Inc
Section 2
SECTION 2: Hazards identification
Not considered hazardous when handled under normal conditions. Accidental ingestion of large amounts may be harmful.
2.1 Classification of the substance or mixture
Not Classified Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions Emergency Overview: Warning: May cause eye and skin irritation. May cause drowsiness if ingested. Medical Conditions Aggravated by Exposure: None known Target Organs: Neurological
Principle Routes of Exposure
Absorption through eyes, ingestion Acute Effects: Eyes Causes painful stinging or burning of eyes and lids, watering of eyes, conjunctivitis, opaqueness of cornea, possibly leading to loss of sight. Skin: May cause irritation. If significant amount absorbed dermally may cause anesthetic or narcotic effects. Inhalation: May cause irritation. If misted, or a high concentrations, may cause pallor, nausea, anesthetic or narcotic effects. Ingestion: Sedative and hypnotic effect in humans at >50mg/kg. Can cause profound sedative-hypnotic effects in animals in doses of 60 mg/kg. Can affect monosynaptic reflexes at 10 mg/kg.
